Ryvu Therapeutics S.A. (RVU.WA)
PLN 36.5
(-3.95%)
PLN 36.5
(-3.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 46.86 Million | 38.8 Million | 11.18 Million | 15.41 Million | 42.56 Million | 77.2 Million |
| Cost of Revenue | 17.55 Million | 17.4 Million | 13.72 Million | 8.76 Million | 92.72 Million | 29.65 Million |
| Gross Profit | 29.3 Million | 21.39 Million | -2.53 Million | 6.64 Million | -50.15 Million | 47.55 Million |
| Operating Expenses | 4.73 Million | 93.07 Million | 75.97 Million | 42.55 Million | -4.98 Million | 61.14 Million |
| Selling, General and Administrative Expenses | 5.67 Million | 5.55 Million | 4.32 Million | 5.46 Million | 4.37 Million | 32.35 Million |
| Research and Development Expenses | - | 25.99 Million | 15.01 Million | 13.01 Million | 67.62 Million | 53.86 Million |
| Other Expenses | -932 Thousand | 61.52 Million | 56.62 Million | 24.07 Million | -9.36 Million | 28.79 Million |
| Cost and Expenses | 147.8 Million | 110.47 Million | 89.7 Million | 51.32 Million | 87.73 Million | 90.79 Million |
| Operating Income | -100.94 Million | -71.67 Million | -77.86 Million | -35.9 Million | -45.13 Million | -13.61 Million |
| Interest Expense | 97 Thousand | 1.08 Million | 197.21 Thousand | 387.43 Thousand | 217.8 Thousand | 291.45 Thousand |
| Income Tax Expense | - | 4.58 Million | 115.94 Thousand | 1.07 Million | -29.99 Thousand | 8.09 Million |
| Earnings before Tax | -92.11 Million | -79.19 Million | -77.41 Million | -30.61 Million | -36.02 Million | 8.98 Million |
| Net Income | -92.11 Million | -83.78 Million | -77.53 Million | -31.68 Million | -35.99 Million | -106.32 Thousand |
| Earnings Per Share Basic | -4.02 | -4.57 | -4.22 | -1.89 | -2.25 | -0.01 |
| Earnings Per Share Diluted | -4.02 | -4.57 | -4.22 | -1.89 | -2.25 | -0.01 |
| Weighted Average Shares Outstanding | 22.89 Million | 18.33 Million | 18.35 Million | 16.76 Million | 15.97 Million | 15.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.89 Million | 18.33 Million | 18.35 Million | 16.76 Million | 15.97 Million | 15.52 Million |
| Gross Margin | 0.63 | 0.55 | -0.23 | 0.43 | -1.18 | 0.62 |
| EBIT Margin | -1.73 | -1.71 | -5.78 | -1.16 | -0.63 | -0.05 |
| Profit Margin | -1.97 | -2.16 | -6.93 | -2.06 | -0.85 | -0.00 |
| EBITDA | -81.04 Million | -65.2 Million | -65.95 Million | -17.87 Million | -35.72 Million | -17.25 Million |
| Earnings Before Tax Margin | -2.15 | -1.85 | -6.96 | -2.33 | -1.06 | -0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 15.74 Million | 21.6 Million | 46.86 Million | 11.19 Million | 12.04 Million | 10.75 Million |
| Cost of Revenue | 3.74 Million | 46.82 Million | 160.3 Million | 40.25 Million | 3.23 Million | 4.45 Million |
| Gross Profit | 12 Million | -25.21 Million | -113.44 Million | -29.06 Million | 8.81 Million | 6.3 Million |
| Operating Expenses | 44.96 Million | 1.1 Million | 4.73 Million | 1.58 Million | 34.15 Million | 36.7 Million |
| Selling, General and Administrative Expenses | 47.56 Million | 687 Thousand | - | 1.35 Million | 701 Thousand | 18.74 Million |
| Research and Development Expenses | - | - | - | 156.72 Million | - | - |
| Other Expenses | 4.49 Million | -416 Thousand | -932 Thousand | -236 Thousand | -284 Thousand | -214 Thousand |
| Cost and Expenses | 48.71 Million | 47.92 Million | 165.04 Million | 41.84 Million | 37.38 Million | 41.15 Million |
| Operating Income | -32.78 Million | -26.32 Million | -118.18 Million | -30.65 Million | -24.28 Million | -31.64 Million |
| Interest Expense | 52 Thousand | 298 Thousand | 97 Thousand | 9000.00 | 8000.00 | 33 Thousand |
| Income Tax Expense | 106 Thousand | 23 Thousand | 10.8 Million | 2.58 Million | 4.99 Million | 3.16 Million |
| Earnings before Tax | -30.31 Million | -19.37 Million | -92.11 Million | -27.75 Million | -18.25 Million | -28.5 Million |
| Net Income | -30.41 Million | -19.39 Million | -92.11 Million | -27.75 Million | -18.25 Million | -28.5 Million |
| Earnings Per Share Basic | -1.40 | -0.84 | - | -1.20 | -0.79 | -1.23 |
| Earnings Per Share Diluted | -1.40 | -0.84 | - | -1.20 | -0.79 | -1.23 |
| Weighted Average Shares Outstanding | 21.72 Million | 23.11 Million | 22.89 Million | 23.12 Million | 23.11 Million | 23.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.72 Million | 23.11 Million | 22.89 Million | 23.12 Million | 23.11 Million | 23.09 Million |
| Gross Margin | 0.76 | -1.17 | -2.42 | -2.60 | 0.73 | 0.59 |
| EBIT Margin | -1.75 | -1.09 | - | -2.50 | -1.37 | -2.39 |
| Profit Margin | -1.93 | -0.90 | -1.97 | -2.48 | -1.52 | -2.65 |
| EBITDA | -27.55 Million | -23.55 Million | - | -28.02 Million | -16.52 Million | -25.68 Million |
| Earnings Before Tax Margin | -2.08 | -1.22 | -2.52 | -2.74 | -2.02 | -2.94 |
FCX
603083
EXAS
COX
2436
000710